CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

About this trial

Last updated 3 months ago

Study ID

GPP-510

Status

Recruiting

Type

Observational

Placebo

Accepting

18+ Years

All Sexes

Trial Timing

Started 3 years ago

What is this trial about?

Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target

What are the participation requirements?

Inclusion Criteria

* A subject must meet all the following criteria to participate in the registry:

1. Has been diagnosed with GPP by a dermatologist or a qualified dermatology practitioner.

2. Is at least 18 years of age and has attained the legal age for consent to procedures involved in the research, under the applicable law of the jurisdiction in which the research is being conducted.

3. Is willing to provide consent for participation in the registry.

4. Is willing to provide Personal Information

Exclusion Criteria

* Any of the following would exclude the subject from participating in the registry:

1. Is participating or planning to participate in a blinded clinical trial evaluating a systemic agent for the treatment or prevention of flares related to GPP.

2. Is enrolled in another CorEvitas registry for a dermatological condition. Subjects enrolled in another CorEvitas registry must be exited to be eligible for enrollment into the GPP Registry